BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 4862377)

  • 1. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease.
    Gianelly R; von der Groeben JO; Spivack AP; Harrison DC
    N Engl J Med; 1967 Dec; 277(23):1215-9. PubMed ID: 4862377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of lidocaine in the treatment of ventricular arrhythmias].
    Antonini FM; Fumagalli C; Bertini G; Ricci F
    Cardiol Prat; 1970 Jun; 21(3):141-54. PubMed ID: 5511551
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
    Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
    Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block.
    Bacaner M
    Geriatrics; 1971 Jan; 26(1):132-48. PubMed ID: 5539447
    [No Abstract]   [Full Text] [Related]  

  • 5. Lidocaine in cardiac arrhythmias.
    Grossman JI; Lubow LA; Frieden J; Rubin IL
    Arch Intern Med; 1968 May; 121(5):396-401. PubMed ID: 5645715
    [No Abstract]   [Full Text] [Related]  

  • 6. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of lidocaine in the prevention of ventricular arrhythmias in the acute phase of myocardial infarct].
    Solimene MC; Bellotti G; Ramires JA; Lage S; Silva LA; Barchi CA; Pileggi F
    Arq Bras Cardiol; 1983 Jun; 40(6):377-81. PubMed ID: 6199006
    [No Abstract]   [Full Text] [Related]  

  • 8. Lidocaine as an antiarrhythmic Experience in 68 patients.
    Flensted-Jensen E; Sandoe E
    Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142
    [No Abstract]   [Full Text] [Related]  

  • 9. [LETTER: Lidocaine per os. Its value in ventricular rhythm disorders].
    Lekieffre J; Thery C; Ginestet A; Carré A; Warembourg H
    Nouv Presse Med; 1975 Jan; 4(3):188-9. PubMed ID: 1129077
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
    Koster RW; Dunning AJ
    N Engl J Med; 1985 Oct; 313(18):1105-10. PubMed ID: 3900727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.
    Rydén L; Waldenström A; Ehn L; Holmberg S; Husaini M
    Br Heart J; 1973 Nov; 35(11):1124-31. PubMed ID: 4128310
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of lignocaine in control of early ventricular dysrhythmias complicating acute myocardial infarction.
    Geddes JS; Webb S; Pantridge JF
    Br Heart J; 1972 Sep; 34(9):964-5. PubMed ID: 5075327
    [No Abstract]   [Full Text] [Related]  

  • 13. Arrhythmias complicating myocardial infarction.
    Fisch C
    J Indiana State Med Assoc; 1971 May; 64(5):419. PubMed ID: 5573761
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lidocaine in ventricular tachycardia caused by acute myocardial infarct].
    Carnevali R; Donati E
    Minerva Cardioangiol; 1974 Feb; 22(2):105-10. PubMed ID: 4594904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of arrhythmias with practolol (Eraldin)].
    Bach-Mortensen N
    Ugeskr Laeger; 1973 Sep; 135(37):1988-92. PubMed ID: 4129852
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effectiveness of lidocaine in patients with ventricular arrhythmias estimated relative to measurements of drug concentration in serum].
    Sinkiewicz W; Marzec A; Hoffman A; Jankowski A; Bartuzi Z; Romański B
    Kardiol Pol; 1989; 32(7-9):366-71. PubMed ID: 2639975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention, clinical aspects and therapy of the side-effects of lidocaine].
    Kettner W; Lenz M; Kettner E; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Oct; 39(20):501-5. PubMed ID: 6516492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the magnesium ion on bathmotropic disorders of the ventricular myocardium].
    Condorelli L
    Boll Soc Ital Cardiol; 1968; 13(4):381-418. PubMed ID: 5733161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intramuscular lidocaine in the treatment of ventricular extrasystole].
    Shapiro M; Paredes A; Guadalajara JF
    Arch Inst Cardiol Mex; 1972; 42(6):908-19. PubMed ID: 4119238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.